Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|18|20|2852-2866
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.18, Iss.20, 2012-07, pp. : 2852-2866
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Protein tyrosine kinase inhibitors in cancer treatment
By Traxler P.M.
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 6, 1997-06 ,pp. :
Selective tyrosine kinase inhibitors
Expert Opinion on Emerging Drugs, Vol. 5, Iss. 3, 2000-10 ,pp. :
Current Cancer Drug Targets, Vol. 10, Iss. 5, 2010-08 ,pp. :